Some of the patients carried C/EBPZ gene mutations, suggesting that the C/EBPZ gene can be used as a diagnosis or prognosis biomarker for the two types of cancer (Herold et al., 2014; Kori and Gov, 2022). The gene discussed is CEBPZ; the disease is cancer.